Vendor, Alachua, FL
Alchem Laboratories Corporation
UEI LD2KY6H7KMQ5, CAGE 3E3D1
17 awards and -$14,008,426 obligated between January 17, 2024 and September 17, 2026, 53% under full and open competition, against 6.5 offers on average where reported. 28 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | $2,070,513 |
| Office of Assistant Secretary for Preparedness and Response | -$16,078,939 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $2,070,513 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$16,078,939 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 9 |
| Full and Open Competition After Exclusion of Sources | 8 |
| Small Business Set Aside - Total | 3 |
| Small Business Set Aside - Partial | 1 |
| Delivery Order | 5 |
| Definitive Contract | 3 |
Hear when Alchem Laboratories Corporation wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Alchem Laboratories Corporation holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $405,000
- Soonest
- June 4, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling pharmaceutical preparation manufacturing to National Institutes of Health, by dollars.
| DLA Troop SupportPhiladelphia, PA | $251,943,801 |
| Pine Pharmaceuticals LLCTonawanda, NY | $1,258,030 |
| United Biopharma, Inc.Hsinchu County | $400,000 |
| Vitae Enim Vitae Scientific, Inc.San Diego, CA | $382,010 |
| On Demand Pharmaceuticals Inc.Rockville, MD | $325,000 |
| Lantheus Biosciences Ltd.Warwick | $248,300 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Drug Manufacturing and Formulation Program (DMFP)
National Institutes of Health, National Institutes of Health Nida
Award noticeNAICS 325412Albany, NY75N95024R00077Awarded to Alchem Laboratories Corporation for $49,999,999
Posted May 514 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91021F00001Delivery Order, February 14, 2024, Full and Open Competition After Exclusion of Sources | NIH NCINational Institutes of Health | Synthesis of Up to Ten Sample Compounds Per Year (Continuity for 66C)NAICS 325412, PSC 6505 | $829,190 |
| 75N91026F00001Delivery Order, September 17, 2026, Full and Open Competition | NIH NCINational Institutes of Health | The NON-GMP Synthesis of Compounds for Drug DiscoveryNAICS 325412, PSC B504 | $600,000 |
| 75N91022F00001Delivery Order, February 14, 2024, Full and Open Competition After Exclusion of Sources | NIH NCINational Institutes of Health | Synthesis of NON-GMP Small Molecules - Incrementally FundedNAICS 325412, PSC 6810 | $405,000 |
| 75N91024F00001Delivery Order, May 31, 2024, Full and Open Competition After Exclusion of Sources, 1 offers | NIH NCINational Institutes of Health | Dfmc- the Purpose of This Task Order Is to Manufacture and Deliver 2200 Capsules of 4MG AZA-TDC (5-Aza-4-Thio-2-Deoxycytidine)NAICS 325412, PSC B504 | $180,220 |
| HHSN261201700020CDefinitive Contract, July 31, 2024, Full and Open Competition After Exclusion of Sources, 2 offers | NIH NCINational Institutes of Health | Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical StudiesNAICS 325412, PSC B504 | $44,538 |
| HHSN261201600066CDefinitive Contract, July 25, 2024, Full and Open Competition After Exclusion of Sources, 6 offers | NIH NCINational Institutes of Health | NON-GMP Synthesis of Compounds for Drug DevelopmentNAICS 325412, PSC B599 | $12,511 |
| 75N91023D00006July 10, 2026, Full and Open Competition, 11 offers | NIH NCINational Institutes of Health | EO14398 Analysis and Synthesis of GMP and NON-GMP Bulk Drugs and Pharmaceutical FormulationsNAICS 325412, PSC B504 | $0 |
| 75N93021D00002December 5, 2024, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | The Contractor Shall Provide Preclinical Development Support for Candidate Products and Drug Development Activities. the Scope of Work EncomNAICS 541715, PSC AN81 | $0 |
| 75N93025D00007September 15, 2025, Full and Open Competition, 13 offers | National Institutes of Health NiaidNational Institutes of Health | Interventional Agents Chemistry ServicesNAICS 541714, PSC AN11 | $0 |
| 75N95019D00028April 28, 2025, Full and Open Competition, 13 offers | National Institutes of Health NidaNational Institutes of Health | Eoi::implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Notice of Termination NAICS 541715, PSC AN11 | $0 |
| 75N95024D00035August 1, 2024, Full and Open Competition, 8 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | IDIQ Chemistry, Manufacturing, and Control (Cmc) and Related Services for Drug ProductsNAICS 325412, PSC AN12 | $0 |
| 75N95026D00007July 30, 2026, Full and Open Competition, 11 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | Eo 14398 Idiq: Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances (Trnd 1)NAICS 325412, PSC AN12 | $0 |
| 75N98019D00057May 30, 2024, Full and Open Competition After Exclusion of Sources, 5 offers | National Institutes of Health OlaoNational Institutes of Health | Drug Formulation and ManufacturingNAICS 325412, PSC R499 | $0 |
| 75N98026D00012May 4, 2026, Full and Open Competition, 7 offersSolicitation | National Institutes of Health OlaoNational Institutes of Health | Ninds Drug Manufacturing and Formulation Program (Dmfp)NAICS 325412, PSC AN11 | $0 |
| HHSN261201700007IJanuary 17, 2024, Full and Open Competition After Exclusion of Sources, 4 offers | NIH NCINational Institutes of Health | EO14042 Synthesis of NON-GMP Small Molecules, Pop: 9/18/17-9/17/22NAICS 325412, PSC B599 | $0 |
| 75N91022F00002Delivery Order, April 23, 2026, Full and Open Competition After Exclusion of Sources | NIH NCINational Institutes of Health | 2026 Udo InitiativeNAICS 325412, PSC 6810 | -$946 |
| 75A50120C00078Definitive Contract, August 5, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | A Multi-Site, Randomized, Double-Blind, Multi-Arm Historical Control, Comparative Trial of the Safety and Efficacy of Hydroxychloroquine andNAICS 541714, PSC AN13 | -$16,078,939 |
- Places of performance
- Florida
- Product and service codes
- 6505 Drugs and BiologicalsB504 Chemical/Biological Studies and Analysis6810 ChemicalsB599 Other Special Studies and AnalysisAN11 Health R&D Services; Health Care Services; Basic ResearchAN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 34 across 17 awards